Condition
Wilms Tumor and Other Childhood Kidney Tumors
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed2
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06674811Recruiting
Biomarkers of Resiliency In Childhood Cancer Surgery
NCT01987596Phase 3Terminated
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
NCT00674193Completed
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT01493817CompletedPrimary
Biomarkers in Samples From Younger Patients With Wilms Tumor
Showing all 4 trials